Technology & Software Global On demand · 24-48h

Global AI Technology in Pharmaceutical Market Strategic Research Report

Name: Global AI Technology in Pharmaceutical Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global AI Technology in Pharmaceutical Market Strategic Rese…

$3,500 USD

Strategic Research Report

Global AI Technology in Pharmaceutical Market

$0B2024

0%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Drug Discovery, Drug Production, Drug Sales, Optimisation Of Clinical Trials, Others

By Application: Pharmaceutical Company, Biotechnology Company, Research Institute, Other

Key Players: IBM, Google, BenevolentAI, Insilico Medicine, Atomwise, GNS Healthcare, Cloud Pharmaceuticals, Exscientia, Cyclica, Recursion, Iktos, Auransa, InveniAI, Deep Genomics

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2024 · forecast to 2032

Length: 109 pages

개요

Scope of the Report

The global AI Technology in Pharmaceutical market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

AI (Artificial Intelligence) technology is making a significant impact on the pharmaceutical industry, transforming various aspects of drug discovery, development, manufacturing, and clinical research. AI"s ability to process large volumes of data, analyze complex patterns, and make predictions has revolutionized the traditional pharmaceutical approaches, leading to more efficient processes and enhanced decision-making.

The global market for AI technology in the pharmaceutical industry was experiencing significant growth, driven by the increasing adoption of AI-powered solutions by pharmaceutical companies to streamline drug discovery, optimize clinical trials, and enhance decision-making processes. The convergence of AI, machine learning, big data analytics, and bioinformatics has led to the development of various AI-based applications tailored to meet the industry"s unique challenges and opportunities. The adoption of AI technology in the pharmaceutical industry was widespread across regions, with North America, Europe, and Asia-Pacific being key markets. North America, led by the United States, dominated the market due to its strong pharmaceutical research and development ecosystem, substantial investment in AI research, and supportive regulatory environment. Europe also accounted for a significant market share, with countries like the United Kingdom, Germany, and France showing notable interest in AI applications in pharmaceuticals. In the Asia-Pacific region, countries like China, Japan, and India were witnessing growth in AI technology adoption for pharmaceutical research and development.

This report presents a comprehensive overview of the global AI Technology in Pharmaceutical market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Drug Discovery
Drug Production
Drug Sales
Optimisation Of Clinical Trials
Others

Segment by Application

Pharmaceutical Company
Biotechnology Company
Research Institute
Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global AI Technology in Pharmaceutical market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Pharmaceutical Company, Biotechnology Company, Research Institute evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type

Drug DiscoveryDrug ProductionDrug SalesOptimisation Of Clinical TrialsOthers

By Application

Pharmaceutical CompanyBiotechnology CompanyResearch InstituteOther

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Drug Discovery
3.1.3 Drug Production
3.1.4 Drug Sales
3.1.5 Optimisation Of Clinical Trials
3.1.6 Others
3.1.7 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Pharmaceutical Company
4.1.3 Biotechnology Company
4.1.4 Research Institute
4.1.5 Other
4.1.6 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 IBM
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Google
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 BenevolentAI
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 Insilico Medicine
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 Atomwise
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 GNS Healthcare
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 Cloud Pharmaceuticals
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Exscientia
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 Cyclica
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Recursion
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Iktos
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Auransa
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 InveniAI
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Deep Genomics
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

How is AI Technology in Pharmaceutical defined?

How is the AI Technology in Pharmaceutical market segmented by type?

By type, the market is segmented into Drug Discovery, Drug Production, Drug Sales, Optimisation Of Clinical Trials and Others.

What are the key applications of AI Technology in Pharmaceutical?

Key applications covered include Pharmaceutical Company, Biotechnology Company, Research Institute and Other.

Which companies are profiled in the AI Technology in Pharmaceutical market report?

Key players profiled include IBM, Google, BenevolentAI, Insilico Medicine, Atomwise, GNS Healthcare, Cloud Pharmaceuticals and Exscientia, among 14 companies covered in total.

What geographies does the AI Technology in Pharmaceutical market analysis include?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What are the key demand drivers for AI Technology in Pharmaceutical?

What are the main risks and barriers in the AI Technology in Pharmaceutical market?

The convergence of AI, machine learning, big data analytics, and bioinformatics has led to the development of various AI-based applications tailored to meet the industry"s unique challenges and opportunities.

Who should buy the AI Technology in Pharmaceutical market report?

The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical Company, Biotechnology Company and Research Institute, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the AI Technology in Pharmaceutical market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.